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Background: Currently over 50% of drugs prescribed to children have not been evaluated properly for use in their
age group. One key reason why children have been excluded from clinical trials is that they are not considered
able to exercise meaningful autonomy over the decision to participate. Dutch law states that competence to
consent can be presumed present at the age of 12 and above; however, in pediatric practice children’s
competence is not that clearly presented and the transition from assent to active consent is gradual. A gold
standard for competence assessment in children does not exist. In this article we describe a study protocol on the
development of a standardized tool for assessing competence to consent in research in children and adolescents.
Methods/design: In this study we modified the MacCAT-CR, the best evaluated competence assessment tool for
adults, for use in children and adolescents. We will administer the tool prospectively to a cohort of pediatric
patients from 6 to18 years during the selection stages of ongoing clinical trials. The outcomes of the MacCAT-CR
interviews will be compared to a reference standard, established by the judgments of clinical investigators, and an
expert panel consisting of child psychiatrists, child psychologists and medical ethicists. The reliability,
criterion-related validity and reproducibility of the tool will be determined. As MacCAT-CR is a multi-item scale
consisting of 13 items, power was justified at 130–190 subjects, providing a minimum of 10–15 observations per
item. MacCAT-CR outcomes will be correlated with age, life experience, IQ, ethnicity, socio-economic status and
competence judgment of the parent(s). It is anticipated that 160 participants will be recruited over 2 years to
complete enrollment.
Discussion: A validity study on an assessment tool of competence to consent is strongly needed in research
practice, particularly in the child and adolescent population. In this study we will establish a reference standard of
children’s competence to consent, combined with validation of an assessment instrument. Results can facilitate
responsible involvement of children in clinical trials by further development of guidelines, health-care policies and
legal policies.
Keywords: Competence, Consent, Assessment, Tool, Drug trial, Informed consent, Decision making, Research, Child,
AdolescentBackground
Introduction
Currently over 50% of drugs prescribed to children have
not been properly evaluated for safety and efficacy in their
age group. One key reason why children have been ex-
cluded from clinical trials is that they are not considered* Correspondence: i.hein@debascule.com
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reproduction in any medium, provided the orcapable of understanding research information. This means
that they are not considered able to exercise meaningful
autonomy over the decision on trial participation. By
Dutch law, competence to consent in children is presumed
to be present at the age of 12 and above. In pediatric cli-
nical practice, though, children’s competence is not that
clearly presented. Children may express an increasing
degree of competence over time as their abilities are deve-
loping, so there is a gradual transition from assent to the
more active consent.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and which were not, it would be possible to involve
them in the decision-making process about clinical trial
participation in a conforming way. Non-competent chil-
dren would no longer have to be burdened by the full
informed-consent procedure, while competent children
would be more actively engaged in that procedure, with
extra weight given to their opinions. This would facilitate
the implementation of clinical trials in children and
adolescents and still protect the vulnerable subjects.
Previous studies show that children’s competence has
never been systematically examined in a standardized
manner [1]. The aim of this study is to develop a stan-
dardized competence assessment tool for children and
to investigate the correlation between competence and
age, IQ and patient characteristics. Once an objective
tool for competence assessment becomes available, it
can be implemented in inclusion stages of clinical trials
in children.
This prospective observational study seeks to examine
whether children’s competence to consent to research




Individuals are competent if they are able to make deci-
sions based on understanding and on rational reasons
[2]. Competent decisions represent informed, free,
self-determined choices and should be respected. This
applies to informed consent as well as to informed refusal.
Competence is task- and context-specific, which means
that assessment of competence should be regarded as a
specific judgment at a specific moment of the ability of
the patient to fulfill the concrete task that he is facing [2].
Legal competence in health care requires being able to
communicate a choice, understanding information one is
given, appreciation of one’s circumstances and mental
capacities to reason and deliberate [3,4].
Legislation
In current pediatric practice, parents and children undergo
an informed consent procedure. According to the Dutch
Medical Treatment Contracts Act (WGBO), which applies
to treatment situations, parents decide for their children
younger than 12 years of age, who are considered by
definition incompetent to act for themselves. For these
children, no actual assessment of competence is necessary.
For children aged 12 to 15, informed consent is required
both from children and parents, provided the children
are judged competent to decide. From 16 years of age,
children are deemed adult in medical decision making. In
the Dutch Medical Research Involving Human Subjects
Act (Wet Medisch-wetenschappelijk Onderzoek met Mensen,WMO), the same arrangements apply but age limits are
set at 12 and 18 years of age. Children are deemed
competent if they appear to understand information
designed for their level of comprehension to an extent
appropriate to the nature and scope of the decision.
Internationally, the statutory age limits differ for clinical
research: the lower age limit varies form 7 to 15, the upper
age limit is set at 17 or 18 years [5].
In the Netherlands, the Doek Committee was installed
to advise the State Secretary of Health, Well-being and
Sports and the Minister of Justice [6] on the desirability
of adapting the current regulations for medical scientific
research with minors that does not benefit them directly.
They concluded that the protection criteria in the Medical
Research Involving Human Subjects Act give children
little room to make decisions based on their own ideas
and values. Children under 12 who wish to refuse partici-
pation in clinical research can formally only make that
known through resistance. Children older than 12 may
withhold permission, but if they do decide to participate,
that can formally be nullified by their parents’ refusal. This
conflicts with the prevailing view that children have the
right to make decisions consistent with their value systems
and life view. Children may be seen as moral agents,
possessing autonomy [7]. The Doek Committee [6]
therefore recommends that the will (the assent or refusal)
of a younger child be taken into account to the degree that
the child can understand the issues. The Task-force in
Europe for Drug Development for the Young [8] issued
recommendations to be implemented Europe-wide,
stating, amongst other things, that minors should be
involved in the informed-consent process in proportion to
age and degree of maturity [65]. By assessing competence
to consent in children and adolescents more objectively
than is now the case, greater justice could be done to the
ideal of respect for the developing autonomy of children
in decision making, in accordance with national and
international recommendations.
Competence assessment in current pediatric practice
At present, clinical investigators are able to make only
intuitive assessments of children’s competence, because
no standardized method is available to test it more
objectively. Conceivably, the age standards prescribed by
law may have too much influence on that intuitive decision
by the assessor. Research evidence indicates that children
under 12 may also be capable of making well-considered
decisions [9,10] and that children as young as 9 can under-
stand the issues involved in clinical trials [10]. This
suggests a mismatch between children’s developmental
level of decision-making maturity and the age limits
set by legislation. The assessment of competence is
subject to two pitfalls: complex research decisions may
be imposed on children who are unable to make them,
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inadvertently excluded [9]. It is recognized that age is,
at best, a proxy for developmental capacity, and that
experience, maturity and psychological state are key
determining factors. This means that children’s compe-
tency to make important decisions ought to be assessed
more individually than is presently the case.
A recent study has shown that doctors and researchers
tend to judge a child as competent if the child’s decision
conforms to their own ideas of the child’s best interest
[11,12]. That means that competence is gauged by the
content of the decision rather than by the process of
reasoning in deciding about participation. It is therefore
vital for clinical researchers to get access to a standar-
dized, objective method to aid them in the informed-
consent procedure, and thus improve the rigor of their
judgment of children’s competence to consent.
Assessment of competence by MacCAT-CR
Until recently, literature on children’s competence assess-
ment was limited. Two reviews [1,10] summarize the
empirical literature on children’s competence to consent
in research and treatment settings. A variety of different
definitions and measures emerge from studies on children’s
competence. Two quantitative instruments, namely the
Competency Questionnaire – Child Psychiatric (CQ-ChP)
[13] and the Hopkins Competency test (HCAT) [14], were
examined, and some other authors (e.g. [15]) used semi-
structured interviews. Only Weithorn’s interview [15]
examined all four sub-domains of competence (see below).
Empirical studies on adults have resulted in a variety
of operational translations of the concept of competence
into assessment instruments. Dunn [16] assessed 23
existing instruments in terms of format, content, features
of administration and psychometric properties and
concluded that the MacArthur Competence Assessment
Tools for Clinical Research (MacCAT-CR) and for
Treatment (MacCAT-T) receive the most empirical
support. These instruments have been tested in particular
in samples of people with dementia, mental disabilities,
schizophrenia and other psychiatric disorders. There
are initial indications of validity [17] and a high degree
of reliability [18].
The MacCAT-CR is a semi-structured interview for-
mat that helps clinical investigators to assess research
candidates’ competence to give informed consent to
participation in trials. It measures the four aspects of
decision-making capability that reflect the standards
for competence to consent in most jurisdictions: (1)
understanding the disclosed information about the nature
of the research and its procedures; (2) reasoning in the
process of deciding about participation, with a focus on
abilities to compare alternatives in the light of their con-
sequences; (3) appreciation of the effects of researchparticipation (or failure to participate) on their own
situation; and (4) expressing a choice about participation
[19]. Whilst an assessment of these abilities is essential,
supplemental information may be needed about a can-
didate’s diagnoses, mental status and medical and social
circumstances [19].
The MacCAT-CR provides a format for disclosing
selected information on the research project at hand. A
standard set of questions then assesses candidates’ abilities
to understand the information, reason about it, appreciate
its consequences and express a choice. The interview
samples their abilities using representative content,
rather than testing them on the full content of a typical
informed-consent disclosure. The MacCAT-CR is based on
the structure of the MacArthur Competence Assessment
Tool for Treatment [17]. In the MacCAT-CR, the number
and focus of questions in each section have been altered
to suit a research context. Unlike the MacCAT-T, the
MacCAT-CR questionnaire does not have to be individua-
lized for each candidate. This facilitates both the research
and the routine use of the interview.
The MacCAT-CR involves two steps: the interview itself
(approximately 15, maximal 20 minutes) and the rating.
The rating criteria provide a way for the assessing clinician
to note opinions on the adequacy or inadequacy of each
item response. The MacCAT-CR provides a summary
rating for each of the four capacities assessed: 0 to 6 for
understanding, 0 to 4 for appreciation, 0 to 8 for
reasoning and 0 to 2 for expressing a choice [19]. A
serious deficit in any of these abilities may translate to
a clinical opinion of incompetence. The scale does not
provide ‘cut-off scores’ that represent competence or
incompetence, nor is there an overall MacCAT-CR total
score [19]. The ratings provide the assessing clinician
with a structured overview of the capacities needed for
competent decision making.
In 2008, a Dutch translation of the MacCAT-T was
made available by van Eyk [20]. Comments on the use of
the MacCAT-T in the Dutch clinical setting were posi-
tive: it was judged as practicable and a valuable addition
to current competence assessment practice [21]. Before
administration, information on the content of the treat-
ment needs to be thoroughly considered by the treating
physician, which was viewed as a major advantage. The
MacCAT-T aided the physician to structure the informa-
tion required for the decision making of the individual
patient [21].
In children, research on the MacCAT scales has been
limited to two small studies. Koelch [22] used an adapted
MacCAT-CR to study the decision-making process in 19
children aged 7 to 15 with psychiatric diagnoses; Tan [23]
used the MacCAT-T to study thinking processes in 10
adolescents aged 13 to 21 with anorexia nervosa. Both
studies confirmed the feasibility of using the MacCAT
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reliability More rigorous research is needed on the applic-
ability of the MacCAT instruments for children.
Child-specific factors in competence judgment
1. Developmental aspects of competence
In children, decision-making abilities develop over
time, as their cognitive, social and emotional abilities
advance. Elementary school children develop the
capacity for logical, systematic thinking using
multiple pieces of information and the ability to
perceive underlying reality despite superficial
appearance. Cognitive advances, social relationships
and emotional development work together to
promote moral development in middle childhood
and children become increasingly able to consider
other people’s feelings [24]. But still, they face
cognitive limitations: they lack the broad base of
knowledge that adults possess. They still sometimes
have trouble combining their cognitive skills into a
larger problem-solving system. They cannot reason
maturely about abstract and hypothetical problems
[25]. In adolescence, the brain undergoes substantial
change with an increase in efficiency of brain
functioning. New cognitive skills such as
hypothetico-deductive reasoning – the ability to
think of hypothetical solutions and to formulate a
systematic plan for deducing which of these solutions
is correct – are acquired [24]. Social cognitive
changes lead to increased maturity in reasoning
about moral issues [25], giving space to altruism.
Even with these advances, compared to adults certain
cognitive limitations remain, mostly involving
inconsistent application of recently acquired
cognitive abilities [25].
The ability to balance risks and benefits depends on
life experience as well as cognitive abilities. Children’s
personal experiences of illness and their responses to
it can provide them with greater insight and
understanding than children of comparable age who
lack this experience [26]. Over time, therapeutic
relationships with children evolve and children grow
and develop, and their response to the experience of
illness alters. Competence assessment should respond
to those changing circumstances.
2. Provision of information
Competence can be enhanced by improvement of
information provision. Children and adolescents do
not have the same comprehension level as adults.
Their abilities to read and write and their working
memory have not reached optimal growth yet. This
implies that the information supply to children
should be tailored to their developmental stage.Techniques for communication include both verbal
and non-verbal forms of information supply, and
breaking up the information into smaller pieces [26].
Information for children needs to be clearly worded,
using simple language, and must connect to the
perception of the child. Innovative techniques can
contribute to conveying information [26]. Children
sometimes need more time [26].
It has been found in current practice that
communication with parents and children is often
flawed [27-29] and even that children are
incompletely informed [11]. As knowledge is a basic
requirement for valid consent [30], assessment of
competence needs to attend to the information
process. Competence assessment taking the real-life
situation as a starting point, containing the necessary
information appropriate to the child’s level of
development, provides the best basis.
3. Systemic influences
Growing-up children are, to a greater extent than
adults, dependent on other people that surround
them, especially their carers or parents. An
exploration of the systemic influences is
indispensable. Children may be particularly
susceptible to the influence of parents and health-
care professionals due to their need for approval or
fear of negative consequences from authority figures
[1,31]. Tates [32,33] states that the communication
pattern in medical meetings is dominated by
adults, and that physicians’ communication is
parent-related. This illustrates the dependence of
children on their parents and physicians for the
information supply and level of involvement. Peer
relations play an important role in development in
middle childhood and adolescence. In interaction
with friends, school-age children adhere very
closely to peer group norms. In early adolescence,
peer influence increases, and then declines [25].
Assessment of competence needs to pay attention
to the influences of important others on the child’s
decision-making process.
Modifications in MacCAT-CR for Children and Adolescents
The original MacCAT-CR by Appelbaum and Grisso
[19] was translated into Dutch by a certified professional
translator. In the next step the language was adapted to a
simple level to be understood by children of elementary
school age. We followed the guidelines of BureauTaal [34]
to adjust the text to groups with low language skills. An
expert on Dutch language and communication, who is
also a teacher at the University of Primary Teachers,
reviewed the text. Three child psychiatrists and three
pediatricians carried out a final review of the text. In our
study, the delivery of the interview has been customized
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dates are asked to participate.
Ditters [21] says in his research that in Dutch clinical
practice some wordings of the MacCAT-T interview and
scoring manual are not familiar. Some of his inter-
viewers showed difficulties understanding the conceptual
framework, and they were uncertain as to when to probe
for the right answer. We tackled this problem by apply-
ing simple language for the interviewers’ instructions
and scoring manual as well. We added directions on
when and how to probe, providing sample sentences.
We aim to make the instrument available to different
disciplines. Similarly, the patient information form and
the informed-consent form for subjects in this study
have been adapted to simple understandable language.
Additional to the worded information, Apppelbaum
[19] recommends that subjects be given a card contain-
ing the disclosed information for each section and
asked to read along as the disclosure is read to them. In
children, reading performance, if present, might not
have reached adult level. Equally, children might have
problems dividing their attention between a written text
and a spoken text. We thought it appropriate not to use
text cards, and to provide cards with pictures disclosing
information about medical procedures unfamiliar to the
patient (e.g. an electroencephalogram) instead of written
information.
The Dutch version of the modified MacCAT-CR for
Children and Adolescents was translated back into English
by another certified professional translator. One of the
original authors of the MacCAT-CR, Appelbaum, provided
comments on this version, which were processed. A special
remark needs to be made on a modification to questioning
the child’s understanding of the consequences of participat-
ing in the trial or not. We added the questions: “What do
you think your parents will think about it if you take part
or don’t take part? And what do you think your friends will
think?” Scoring the answers, we note whether the child can
mention consequences for daily life or social relations.
With this approach we give more attention to the influ-
ence of social relationships than in the adult version of
MacCAT-CR.
Methods/design
This study is a prospective cohort study comparing
competence judgment by using observational techniques to
outcomes of the MacCAT-CR for Children and Adolescents,
while at the same time assessing competency-related
patient data.
Methods/design
The validity and reliability of the translated and modified
MacCAT-CR for Children and Adolescents will be
assessed in a sample of children who are candidates toparticipate in ongoing medical trials. A reference standard
for competence will be established first. The usual informed-
consent procedure will be performed by the clinical
investigators, and they will record their own intuitive
clinical judgment of a child’s consent competence. At
this point, parents will also be asked to judge whether
their child has understood and is able to make a well-
considered decision. This informed consent procedure will
be videotaped. The recordings will then be reviewed
independently by two experts (child psychiatrists, child
psychologists or medical ethicists), who will also record
a judgment on the child’s consent competence. This
will allow us to estimate the inter-examiner reproduci-
bility of the informed-consent procedure.
To establish a reference standard for consent compe-
tency, any discordant decisions for a child’s consent
competency of the two experts and the clinician will be
examined. If there is any discrepancy between the three
evaluators’ judgments, a consensus decision will be
reached after discussion. The final decisions will form
the reference standard for competence.
After the usual informed-consent procedure, within
48 hours the MacCAT-CR interview will be adminis-
tered by the researchers, independent of the first clinical
judgment; these interviews will also be videotaped. The
interviewers consist of specially trained special education
or psychology graduates. The interviews will be scored
by the administrator and independently by two experts
(a multidisciplinary team of child psychiatrists, psycholo-
gists and medical ethicists). A yes/no decision will be made
following the guidelines in the MacCAT-CR manual.
Demographic patient data will be collected and the
Wechsler Nonverbal Scale of Abilities short version will
be administered within two months of the interviews.
Objectives
The final objectives are (1) to assess the reproducibility
of MacCAT-CR scores and yes/no judgments of compe-
tence to consent, and (2) to establish a reference standard
to which MacCAT-CR scores can be compared to evaluate
the criterion-related validity of the instrument (in the
absence of a criterion test for competence to consent).
The reference standard will also be used to (1) estimate
optimal cut-off scores on the MacCAT-CR scale that
minimizes false positive and false negative decisions, and
(2) determine ages for informed consent and compare
these to current statutory age limits. The agreement
between the reference standard and the judgment of the
parent(s) will also be examined.
Subjects
One hundred and sixty pediatric patients aged 6 to 18
who are involved in the selection stages of ongoing
medical trials will be recruited. These will be trials that
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age and diagnosis (including childhood oncology, lung
disease and ophthalmology). The children will be
selected consecutively in the order of recruitment for
the trials. The lower age limit of 6 is justifiable as
younger children cannot be expected in developmental
terms to be capable of meaningfully answering the
interview questions. Age distribution will be structured in
a way that approximately 70% of the sample (± 1 z-score)
will be aged 8 to 14, because the transition point in
competence is expected to occur there. The purpose is
to avoid overestimating reproducibility and criterion
validity as a result of excessive contrast in the age
distribution. Grounds for exclusion will be insufficient
fluency in Dutch.Measures
The outcome measures of the MacCAT-CR will be a total
score, domain scores, and a binary assessment (yes/no)
of a child’s competence to consent. Clinical investiga-
tors and parents will also be asked to give their prior
intuitive yes/no assessments of the child’s competence
to decide.
The Wechsler Nonverbal Scale of Ability short version
(WVN) will be used to assess children’s intelligence
quotient. The WNV is a clinical instrument for examining
cognitive capacities of children and adolescents aged 4 to
21. The WVN is suitable for the general population as well
as for children with cultural, linguistic, educational or
socio-economic varying backgrounds. The subtests do
not invoke verbal capacities as instructions are made by
pictograms. Different subtests are to be administered in
children from 4 to 7 and from 8 to 21. The short version
for the first age group consists of matrix reasoning and
recognizing, and for the second age group matrix reason-
ing and spatial orientation [35]. For practical reasons the
short version is chosen: the two subtests take 20 minutes
together. The full version gives more rigorous outcomes
and has psychometrical advantages, but the validity and
reliability of the short version are good. In this study the
subjects cannot be burdened by the long version due to
possible pain or distress. The WNV is the only IQ test
with a standardized short version; this is in contrast to the
Wechsler Intelligence Scale for Children. The WNV is
approved by the Dutch Committee on Tests and Testing
Affairs (COTAN). The WNV will be administered by
trained certified professionals (special education or
psychology graduates) under supervision of a senior
professional.
The highest level of education of the highest-educated
parent will be noted as an indicator of socio-economic
status. Duration of disease, number of trials previously
participated in and ethnicity will be noted.Informed-consent procedure
Prior written consent to take part in this study will be
requested from all child participants and their parents,
separate from any consent required of them for the drug
trials. The pediatric patients sampled for the drug trials
will be informed together with their parents by the
trained clinical investigator about the competence stu-
dy at the same time as they are informed about the
drug trial. They will also be free to choose participa-
tion in one of the two studies with no consequences
for the other. The outcome of the MacCAT-CR inter-
view will not affect the conduct of the drug trial being
carried out by the investigator. The ethics committee
of the Academic Medical Center Amsterdam in the
Netherlands confirmed that the Medical Research In-
volving Human Subjects Act (WMO) does not apply
to this study and the committee makes no objections
to the implementation.Statistical analysis
Descriptive summaries of demographic and assessment
outcome measures will be generated with respect to all
subject characteristics.
Reliability: Statistical analysis will include exploration
of internal consistency, by estimating Cronbach’s alpha
for the items of each subscale and for the total scale.
We will also calculate adjusted item-to-scale total
correlations. Factor analysis and item response theory
methods (Rasch analysis) will be used to further test
scale unidimensionality. To optimize the MacCAT-CR
scoring system and to determine necessary item weights,
we will use a specific extension of the Rasch measurement
model One Parameter Logistic Model (OPLM) [36].
Conditional maximum likelihood estimation methods will
be used to obtain stable item parameters.
Criterion-related validity: The overall accuracy of the
MacCAT-CR score in classifying competence against
the reference standard will be quantified using receiver
operator characteristic curve (ROC) analysis. The area
under the ROC curve (AUC) will serve as the validity
coefficient; this may range from 50% (chance determin-
ation) to 100% (perfect determination). The optimal
MacCAT cut-off score and the accompanying sensitivity
and specificity rates will be determined using Youden’s
method, the cut-off score corresponding to the fewest
false positive and false negative classifications. Against
our current expectations, this may give an indication of
a single score above which competence is more likely.
The validity of the current statutory cut-off ages will be
tested by the same method, but using age as the
predictor of capacity to provide informed consent.
Inter-rater reproducibility: We will determine inter-rater
reproducibility (1) for the clinical judgment on competence
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MacCAT-CR total and subscale scores, (3) for the yes/no
outcome of the reference standard and the yes/no outcome
of the MacCAT-CR, and (4) for the yes/no outcome of the
reference standard and the yes/no decision of the parents.
We will quantify reproducibility with intraclass correlation
coefficients for total scores on the MacCAT-CR scales.
Inter-rater reproducibility of the item scores will be
quantified by calculating weighted Kappa coefficients.
To quantify the reproducibility of the yes/no outcome
for competence to consent, multi-rater (unweighted)
Kappa or simple Cohen’s Kappa will be used in the case
of pairwise comparisons. We have a special interest in
children between 8 and 14 years, and we will compare
the ICCs and Kappa values calculated for children in
this age group separately.
Statistical power analysis: There is no general agreement
about estimating suitable sample size for the psychometric
(factor-analytic, Rasch analytic) evaluation of multi-item
scales. Simulation studies for the related techniques of
regression analysis indicate that a minimum of 10 to 15
observations per variable (item) are needed to obtain
stable estimates. For the 13 items of the MacCAT-CR this
would result in 130 to 190 observations. Judging from
previous studies on MacCAT-CR and MacCAT-T in
adults with compromised decisional capacities [18,37-39],
our proposed sample size of N=160 is justifiable. In view
of the three raters involved in our assessment of inter-
rater reproducibility, the intraclass correlation for the
MacCAT-CR score can be estimated with ±5% accuracy
around the expected level of 0.80 with 95% certainty. The
Kappa for the yes/no capacity to consent decision can be
estimated with ±11% accuracy and 95% certainty assuming
60% raw agreement between two raters and an expected
Kappa of 0.70.
An ROC-AUC validity statistic of 0.80 (null hypothesis
AUC 0.69) can be detected with 80% power assuming a
3:1 ratio of test positive (competent to consent) and test
negative children. Sensitivity and specificity rates of the
MacCAT-CR cut-offs obtained by Youden’s method can
be estimated with ±7% accuracy, assuming 0.75 as the
expected value. For the Rasch analysis, the MacCAT-CR
outcomes from the raters will be combined. Data
dependency will not be an issue in our use of conditional
maximum likelihood estimation methods, because the
method makes no assumptions about the distribution of




Due to the lack of a gold standard for competence
assessment, the reference standard will be established
according to current best clinical practice by physiciansthat deal with competence assessment in pediatric
practice. The expert opinion represents the clinical
conception of competence in children. These judgments
constitute the best possible starting point. It is possible,
however, that competence judgments vary between
evaluators. Previous research demonstrates that unaided
competence judgments, even of clinicians, are not reliable.
Kim [40] describes considerable variety in competence
judgments between experienced psychiatrists in a popula-
tion of geriatric patients asked to participate in a hypo-
thetical trial. Inter-rater reliability with group Kappa
statistics ranges from fair to moderate agreement (0.40
to 0.45) for the psychiatrists’ judgments. The authors
recommend more effective training in the judgment of
competence to consent to research, as well as a judgment
method. In this study this recommendation has been
adopted: the expert panel that is to review the videos will
be instructed and provided with basic information on
competence judgment.
Another limitation might be that the same version of
the MacCAT-CR will be administered to the whole
range of children aged 6 to 18. Undoubtedly cognitive
abilities and language skills vary widely in this age group. A
pilot study did reveal some minor problems in 6-year-old
children who did not understand the disclosed information
and needed frequent rehearsal. Some of the older children
understood easily, and they were not bothered by the
simple language level.Recommendations
A validity study on an assessment tool of competence to
consent is badly needed in research practice, particularly in
the child and adolescent population. As far as we know,
this is the first large-scale empirical study worldwide trying
to establish a reference standard for children’s competence
to consent, combined with validation of an assessment
instrument. Results could lead to further development of
guidelines, health-care policies and legal policies.
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